SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MAXY - Maxygen, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (75)7/19/2001 5:31:23 AM
From: nigel bates  Read Replies (1) | Respond to of 262
 
Message 16096799
Maxygen is doing what larger companies often do: It's sitting back and waiting to see if tiny Kosan can really work antibiotic wizardry. "What we are doing in this area at the moment is nothing," says Russell Howard, chief executive of Maxygen. In order to make these drugs, "we would really form some kind of alliance with companies like Kosan."...


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News